Patent for EU
- BioVentures
- Aug 28, 2020
- 1 min read
Updated: Dec 28, 2020
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes has been granted with European Union patent no EP 3 134 426 B1.
Comentários